Evidence map›Paper›PMID 38379356›Full record

ArticleAnimal models and experimental medicine2024

"Baihui" (DU20)-penetrating "Qubin" (GB7) acupuncture on blood-brain barrier integrity in rat intracerebral hemorrhage models via the RhoA/ROCK II/MLC 2 signaling pathway.

Ce Zhang, Jia Zheng, Xueping Yu, Binglin Kuang, Xiaohong Dai, Lei Zheng, Weiwei Yu, Wei Teng, Hongtao Cao, Mingyue Li and 3 more

Abstract read
In one paragraph

Article in Animal models and experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Acupuncture alleviates secondary brain injury in intracerebral hemorrhage-induced rats through activating the LKLF/Mfn2 pathway.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ce ZhangHeilongjiang University of Chinese Medicine, Harbin, China.ORCID 0000-0002-0537-9588
Jia ZhengHeilongjiang University of Chinese Medicine, Harbin, China.
Xueping YuFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Binglin KuangHeilongjiang University of Chinese Medicine, Harbin, China.
Xiaohong DaiFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Lei ZhengClinical Key Laboratory of Integrated Traditional Chinese and Western Medicine of Heilongjiang University of Chinese Medicine, Harbin, China.
Weiwei YuFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Wei TengFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Hongtao CaoFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Mingyue LiFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Jiayong YaoFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Xiaoying LiuFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Wei ZouFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

Funding

National Natural Science Foundation of China 81473764National Natural Science Foundation of China 81774416
6 · The paper itself

Abstract

backgroundBlocking the RhoA/ROCK II/MLC 2 (Ras homolog gene family member A/Rho kinase II/myosin light chain 2) signaling pathway can initiate neuroprotective mechanisms against neurological diseases such as stroke, cerebral ischemia, and subarachnoid hemorrhage. Nevertheless, it is not clear whether and how disrupting the RhoA/ROCK II/MLC 2 signaling pathway changes the pathogenic processes of the blood-brain barrier (BBB) after intracerebral hemorrhage (ICH). The present investigation included the injection of rat caudal vein blood into the basal ganglia area to replicate the pathophysiological conditions caused by ICH.

methodsScalp acupuncture (SA) therapy was performed on rats with ICH at the acupuncture point "Baihui"-penetrating "Qubin," and the ROCK selective inhibitor fasudil was used as a positive control to evaluate the inhibitory effect of acupuncture on the RhoA/ROCK II/MLC 2 signaling pathway. Post-assessments included neurological deficits, brain edema, Evans blue extravasation, Western blot, quantitative polymerase chain reaction, and transmission electron microscope imaging.

resultsWe found that ROCK II acts as a promoter of the RhoA/ROCK II/MLC 2 signaling pathway, and its expression increased at 6 h after ICH, peaked at 3 days, and then decreased at 7 days after ICH, but was still higher than the pre-intervention level. According to some experimental results, although 3 days is the peak, 7 days is the best time point for acupuncture treatment. Starting from 6 h after ICH, the neurovascular structure and endothelial cell morphology around the hematoma began to change. Based on the changes in the promoter ROCK II, a 7-day time point was selected as the breakthrough point for treating ICH model rats in the main experiment. The results of this experiment showed that both SA at "Baihui"-penetrating "Qubin" and treatment with fasudil could improve the expression of endothelial-related proteins by inhibiting the RhoA/ROCK II/MLC 2 signaling pathway and reduce neurological dysfunction, brain edema, and BBB permeability in rats.

conclusionThis study found that these experimental data indicated that SA at "Baihui"-penetrating "Qubin" could preserve BBB integrity and neurological function recovery after ICH by inhibiting RhoA/ROCK II/MLC 2 signaling pathway activation and by regulating endothelial cell-related proteins.

Indexed as

Acupuncture TherapyBlood-Brain BarrierCerebral HemorrhageDisease Models, AnimalMyosin Light ChainsRats, Sprague-DawleyrhoA GTP-Binding Proteinrho-Associated KinasesSignal Transduction1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAcupuncture PointsAnimalsCardiac MyosinsMaleRatsrho GTP-Binding Proteins1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineCardiac Myosinsfasudilmyosin light chain 2Myosin Light ChainsrhoA GTP-Binding ProteinRhoA protein, ratrho-Associated Kinasesrho GTP-Binding ProteinsROCK2 protein, ratblood–brain barriercaveolaeintracerebral hemorrhageRhoA/ROCK II/MLC 2 signaling pathwayscalp acupuncture

Identifiers

PMID38379356
PMCPMC11528382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.